# Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension

> **NCT00419796** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 78 (estimated)

## Conditions studied

- Osteoarthritis With Controlled Hypertension

## Interventions

- **DRUG:** Lumiracoxib

## Key facts

- **NCT ID:** NCT00419796
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2007-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419796, "Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00419796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*